A Little Late But Great PR News...Protokinetix..
ProtoKinetix Completes Sale of Exclusive Rights for AAGP™ Blood Preservation Applications
VANCOUVER, British Columbia--(BUSINESS WIRE)--
ProtoKinetix (PKTX) (www.protokinetix.com) has announced the sale of one of the numerous cell protection applications that prove to significantly increase the shelf life of delicate cells and organs by the addition of AAGP™. The purchaser, Intrepid Innovations Corporation, is a wholly owned subsidiary of Umbra Applied Technologies Group (UATG) and has been funded to address the world-wide demand for blood product storage, and platelet preservation.